Well, Tom can take this specific breakdown. But yes, the tech-enabled business, our B2B business performed, I would say, compared to the rest of the market exceptionally well and continues to do well. Our ISV business domestically is oriented a lot to hospitality, so obviously, for the portion that relates to hospitality, that's been adversely affected. But the rest of the ISV business did quite well. Our - turning to Europe, for example, our UK business, which is predominantly ISV oriented probably was one of the best performers that we had. Our Canadian business as well had actually a breakout year, probably the best year it's had in terms of its tech-enabled business. So we definitely had very strong pockets across the markets, Mexico as well as a big push into that channel. If you recall, we bought a company, I think, almost 2 years ago, SF systems, and the team came across, and that has anchored us to pursue that market. So I would say, without question, that performed somewhat, irrespective of the impact of the pandemic. The big box business, as Tom was outlining, in our major markets, likewise, did very well. As the markets came - come back, seeing what we saw over the summer, I think it all comes back somewhat equally. I think the businesses that have largely been shuttered or have minimal business, those will open up. I think there'll be an initial strong -- very strong rebound, and then it should settle in to a rhythm that we would have historically seen. I think the one benefit the industry is going to see is the muscle memory now to use card over cash, whether there's a concern of the spread versus just - it's easier to use card. I think our industry will clearly benefit. And we saw that in numbers again over the summer, where our volumes, even with, say, 15% of our merchants closed, because of the pandemic, our volumes were at or above where they had been in the prior year. So the only difference there is people are spending more on cards than they did the prior year. So we'll expect to see the benefit of all that, as these vaccinations impact government decisions on how they're going to treat their citizens. But Tom, can you give you a breakout.